FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088381 [Registered on: 06/06/2025] Trial Registered Prospectively
Last Modified On: 05/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   Finding the appropriate dose of morphine to be given in the spinal fluid for achieving good pain relief for 24 hours after robotic prostate surgery. 
Scientific Title of Study   Determining the effective dose (ED50) of intrathecal morphine for postoperative analgesia in patients undergoing robotic prostate surgery. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ajisha Aravindan 
Designation  Associate Professor 
Affiliation  All India Institute of Medical Science 
Address  Dept of Anaesthesiology, Pain Medicine and Critical Care, Room 14, Porta Cabin,4th Floor, Academic Block, AIIMS, Ansari Nagar

South
DELHI
110029
India 
Phone  9810597276  
Fax    
Email  ajishaa@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Priyankar Kumar Datta 
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Science 
Address  Dept of Anaesthesiology, Pain Medicine and Critical Care, 5th Floor, Academic Block, AIIMS, Ansari Nagar

South
DELHI
110029
India 
Phone  9830771756  
Fax    
Email  priyankar.k.datta@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Keerthana G 
Designation  Junior Resident 
Affiliation  All India Institute of Medical Science 
Address  Dept of Anaesthesiology, Pain Medicine and Critical Care, 5th Floor, Academic Block, AIIMS, Ansari Nagar

South
DELHI
110029
India 
Phone  6379323480  
Fax    
Email  keerthigaja116@gmail.com  
 
Source of Monetary or Material Support  
All India Institute of Medical Science, Ansari Nagar, New Delhi -110029 
 
Primary Sponsor  
Name  All India Institute of Medical Science 
Address  Ansari Nagar New Delhi 110029 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ajisha Aravindan  All India Institute of Medical Sciences  Department of Anaesthesiology, Pain Medicine and Critical Care,5th floor. Academic block, Ansari Nagar New Delhi 110029
South
DELHI 
01126594195

ajishaa@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
AIIMS Institute Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Intrathecal morphine  Based on Dixons up and down methodology different doses of preservative-free intrathecal morphine along with 1 ml of 0.5% bupivacaine (heavy) will be administered to each patient prior to induction of general anaesthesia as a single shot injection in the lumbar spine with a 25 G spinal needle.  
Comparator Agent  Not applicable  Not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Adult ASA physical status I or II patients undergoing robotic prostate surgery. 
 
ExclusionCriteria 
Details  a)Patients refusal to participate in the study
b)BMI more than 30 and less than 18
c)Contraindications to neuraxial anaesthesia
d)Allergy to bupivacaine or morphine
e)High probability of moderate- severe OSA (STOP BANG more than 4)
f)Poorly controlled COPD
g)Severe LV systolic dysfunction
h)CNS disease
i)CKD stage 4 and 5
j)Unable to communicate effectively 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Other 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To determine the median effective dose (ED50) of intrathecal morphine that provides adequate post-operative analgesia   Upto 24 hours from the end of surgery 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the quality of post-operative recovery using Quality of Recovery (QoR-15) score


 
After 24 hours from the end of surgery. 
To find out the incidence of adverse effects of intrathecal morphine  Upto 24 hours from the end of surgery 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [ajishaa@gmail.com].

  6. For how long will this data be available start date provided 01-08-2025 and end date provided 31-12-2035?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Study sample

1.     Data collection for determining ED50 with 95 percent CI will begin with the 3rd cross-over pair.

2.     This protocol will be continued for further 7 successes to failure crossovers pairs.

3.  Expected sample size of 40 patients.

Study protocol

All patients will undergo a detailed pre-anaesthetic examination as per the institute protocol at least one day before the surgery. Preoperative investigations including complete hemogram, serum electrolytes and renal function test will be recorded as per standard protocol.

In the operating room, standard monitoring as per American Society of Anaesthesiologists recommendation (ECG, pulse oximetry, non-invasive BP) will be done. An 18G IV cannula will be inserted in all patients. Balanced salt solution (RL or Plasmalyte) will be started.


Patients will be positioned for spinal anaesthesia in sitting or lateral position. Preservative-free intrathecal morphine (ITM) along with 1 ml of 0.5 percent bupivacaine (heavy) will be administered prior to induction of general anaesthesia as a single shot injection in the lumbar spine with a 25 G spinal needle under aseptic precautions.


Protocol for dose titration of ITM

Dose titration will follow the modified Dixon’s up and down method. Dose for first patient will be 50 mcg of intrathecal morphine ITM diluted in a volume on 1 ml of 0.5 percent heavy bupivacaine. If this dose leads to analgesic failure, subsequent doses will be increased by 25 mcg. Once analgesic success is achieved, subsequent doses will be decreased by 25 mcg till analgesic failure is encountered at which subsequent doses will be again increased by 25 mcg.


Standard induction of general anesthesia will be done as per the preference of the anesthesia team with 2 mcg per kg of IV Fentanyl. Anaesthesia will be maintained with isoflurane and muscle relaxation will be achieved by intermittent boluses or a continuous infusion of intermediate acting non-depolarizing muscle relaxant atracurium. Intraoperative fluid protocol will be decided by the attending anaesthesiologist and the amount of intraoperative fluid administered (crystalloid, colloid, blood and blood products) will be noted. All the patients will be catheterized perioperatively as per surgical protocol.


Intraoperative analgesia protocol

Patients will receive 2 mcg per kg IV fentanyl at induction and 1 mcg per kg IV fentanyl bolus whenever there is need for analgesia as deemed by the treating anesthesiologist. Patient will also receive 15 mg per kg IV paracetamol and 0.5 mg per kg IV ketorolac.

At the end of surgery, neuromuscular blockade will be reversed, and patient will be extubated. All patients will be closely monitored for 24 hours.


In PACU, standard monitoring consisting of non-invasive blood pressure, ECG, pulse oximetry will be used. Patients will receive 15 mg per kg IV Paracetamol every 6 hours and PCA fentanyl (25mcg IV bolus with lock-out interval of 10 min, maximum 4 hour limit of 400 mcg, with no background infusion).


Postoperative NRS scores will be monitored on awakening from anaesthesia and at 6, 12, 18 and 24 hours.

ANALGESIC FAILURE will be defined if the average NRS score more than 4 or patient PCA fentanyl demand more than 4mcg per kg IV at the end of 24 hours.

ANALGESIC SUCCESS will be defined if the average NRS score less than 4 or patient PCA fentanyl demand less than 4mcg per kg IV at the end of 24 hours.


During the first 24 hours in the PACU, the occurrence of side effects like nausea, vomiting, pruritus, post-dural puncture headache and respiratory depression will be noted and treated with appropriate therapy.


Respiratory depression will be defined as respiratory rate less than 8 breaths per minute and treated as per the patient’s clinical conditions by the attending anaesthesiologist.


The quality of post-operative recovery will be assessed at the end of 24 hours in PACU using the QoR-15 score.

 
Close